Track topics on Twitter Track topics that are important to you
Multinationals are in line for a windfall from President Donald Trump's call to cut the tax rate on U.S. companies' stockpiled overseas earnings, but a select few would do better than others. Apple Inc. and Pfizer Inc. may enjoy an extra earnings bump because of their previous accounting maneuvers, while companies including Microsoft Corp., Merck & Co.
Original Article: Trump's Offshore Tax Plan May Mean Perk for Apple, PfizerNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...